Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease

Neurobiology of Aging

Volumn 35, Issue 6, 2014, Pages 1512.e5-1512.e10

  Dong, Jing ^a   Gao, Jianjun ^a,b   Nalls, Michael ^c   Gao, Xiang ^d,e   Huang, Xuemei ^f   Han, Jiali ^e   Singleton, Andrew B ^c   Chen, Honglei ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Melanoma; Parkinson's disease; Pigmentation; Susceptibility

Indexed keywords

AGED; ARTICLE; ASIP GENE; CANCER DIAGNOSIS; CAUCASIAN; CONTROLLED STUDY; EYE COLOR; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAIR COLOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN COLOR; SKIN PIGMENTATION; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; PIGMENTATION; RISK;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MELANOMA; PARKINSON DISEASE; PHENOTYPE; PIGMENTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84903363928     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.12.020     Document Type: Article

References (20)

1. Bajaj A., Driver J.A., Schernhammer E.S. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control 2010, 21:697-707.
2. Bertoni J.M., Arlette J.P., Fernandez H.H., Fitzer-Attas C., Frei K., Hassan M.N., Isaacson S.H., Lew M.F., Molho E., Ondo W.G., Phillips T.J., Singer C., Sutton J.P., Wolf J.E. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch. Neurol. 2010, 67:347-352.
3. Bishop D.T., Demenais F., Iles M.M., Harland M., Taylor J.C., Corda E., Randerson-Moor J., Aitken J.F., Avril M.F., Azizi E., Bakker B., Bianchi-Scarra G., Bressac-de Paillerets B., Calista D., Cannon-Albright L.A., Chin A.W.T., Debniak T., Galore-Haskel G., Ghiorzo P., Gut I., Hansson J., Hocevar M., Hoiom V., Hopper J.L., Ingvar C., Kanetsky P.A., Kefford R.F., Landi M.T., Lang J., Lubinski J., Mackie R., Malvehy J., Mann G.J., Martin N.G., Montgomery G.W., van Nieuwpoort F.A., Novakovic S., Olsson H., Puig S., Weiss M., van Workum W., Zelenika D., Brown K.M., Goldstein A.M., Gillanders E.M., Boland A., Galan P., Elder D.E., Gruis N.A., Hayward N.K., Lathrop G.M., Barrett J.H., Bishop J.A. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 2009, 41:920-925.
4. Ferreira J.J., Neutel D., Mestre T., Coelho M., Rosa M.M., Rascol O., Sampaio C. Skin cancer and Parkinson's disease. Mov. Disord. 2010, 25:139-148.
5. Gao J., Huang X., Park Y., Liu R., Hollenbeck A., Schatzkin A., Mailman R.B., Chen H. Apolipoprotein E genotypes and the risk of Parkinson disease. Neurobiol. Aging 2011, 32:2106.e1-2106.e6.
6. Gao X., Simon K.C., Han J., Schwarzschild M.A., Ascherio A. Family history of melanoma and Parkinson disease risk. Neurology 2009, 73:1286-1291.
7. Gao X., Simon K.C., Han J., Schwarzschild M.A., Ascherio A. Genetic determinants of hair color and Parkinson's disease risk. Ann. Neurol. 2009, 65:76-82.
8. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., Benediktsdottir K.R., Thorisdottir K., Ragnarsson R., Sveinsdottir S.G., Magnusson V., Lindblom A., Kostulas K., Botella-Estrada R., Soriano V., Juberias P., Grasa M., Saez B., Andres R., Scherer D., Rudnai P., Gurzau E., Koppova K., Kiemeney L.A., Jakobsdottir M., Steinberg S., Helgason A., Gretarsdottir S., Tucker M.A., Mayordomo J.I., Nagore E., Kumar R., Hansson J., Olafsson J.H., Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 2008, 40:886-891.
9. Han J., Kraft P., Nan H., Guo Q., Chen C., Qureshi A., Hankinson S.E., Hu F.B., Duffy D.L., Zhao Z.Z., Martin N.G., Montgomery G.W., Hayward N.K., Thomas G., Hoover R.N., Chanock S., Hunter D.J. Agenome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008, 4:e1000074.
10. Herrero Hernandez E. Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies. Med. Hypotheses 2009, 72:280-284.
11. Inzelberg R., Israeli-Korn S.D. The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers. J.Neural. Transm. 2009, 116:1503-1507.
12. Kareus S.A., Figueroa K.P., Cannon-Albright L.A., Pulst S.M. Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch. Neurol. 2012, 69:1572-1577.
13. Lin S.W., Wheeler D.C., Park Y., Cahoon E.K., Hollenbeck A.R., Freedman D.M., Abnet C.C. Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int. J. Cancer 2012, 131:E1015-E1023.
14. Liu R., Gao X., Lu Y., Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011, 76:2002-2009.
15. Meng S., Song F., Chen H., Gao X., Amos C.I., Lee J.E., Wei Q., Qureshi A.A., Han J. No association between Parkinson disease alleles and the risk of melanoma. Cancer Epidemiol. Biomarkers Prev. 2012, 21:243-245.
16. Mitra D., Luo X., Morgan A., Wang J., Hoang M.P., Lo J., Guerrero C.R., Lennerz J.K., Mihm M.C., Wargo J.A., Robinson K.C., Devi S.P., Vanover J.C., D'Orazio J.A., McMahon M., Bosenberg M.W., Haigis K.M., Haber D.A., Wang Y., Fisher D.E. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 2012, 491:449-453.
17. Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
18. Olsen J.H., Jorgensen T.L., Rugbjerg K., Friis S. Parkinson disease and malignant melanoma in first-degree relatives of patients with early-onset melanoma. Epidemiology 2011, 22:109-112.
19. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Jakobsdottir M., Steinberg S., Gudjonsson S.A., Palsson A., Thorleifsson G., Palsson S., Sigurgeirsson B., Thorisdottir K., Ragnarsson R., Benediktsdottir K.R., Aben K.K., Vermeulen S.H., Goldstein A.M., Tucker M.A., Kiemeney L.A., Olafsson J.H., Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K. Two newly identified genetic determinants of pigmentation in Europeans. Nat. Genet. 2008, 40:835-837.
20. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., Manolescu A., Karason A., Palsson A., Thorleifsson G., Jakobsdottir M., Steinberg S., Palsson S., Jonasson F., Sigurgeirsson B., Thorisdottir K., Ragnarsson R., Benediktsdottir K.R., Aben K.K., Kiemeney L.A., Olafsson J.H., Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 2007, 39:1443-1452.